This month we dip our toes into the challenging waters of sentinel lymph node biopsy (SLNB). This is always a contentious topic, with debate focussed around its utility in diagnosis and staging, and its role in therapy both as a part of node excision but also access to immunotherapy.
For more information on this topic, you may be interested in the HealthCert Professional Diploma in Skin Cancer Medicine: medical courses online + with optional workshops ideal for GP training towards a focused interest in skin cancer.
The landscape is changing fairly rapidly, especially as the role of immunotherapy and other novel treatments further evolve and are being used more in early stage melanoma.
This paper, published in DPC recently, explores this topic in a very practical and pragmatic way and makes for very useful reading.
Of course we need to follow our local health service guidance around referral for SLNB, but this can usefully be informed by papers such as this when we have our own conversations with patients.
– Prof David Wilkinson
For further information on this topic, you may be interested in the HealthCert Professional Diploma in Skin Cancer Medicine.
Read another research summary from Prof David Wilkinson: Photodynamic therapy to treat field cancerisation
Engaging with this blog can help meet your annual
|
If you consume educational webinars, podcasts, articles, or research on this blog, you can Quick Log CPD hours with the RACGP via the usual self-submission process. You will be asked to reflect on what you have learned, and you will require supporting evidence such as a screenshot. Download the RACGP’s guide to self-recording your CPD here. |